P3 Health Partners (PIII) Names Atul Kavthekar Chief Financial Officer

December 1, 2022 4:33 PM EST

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced Atul Kavthekar will be joining the Company as Chief Financial Officer (CFO), on December 12, 2022.

As CFO, Mr. Kavthekar will lead the Company’s finance organization and will oversee Accounting, Treasury, Finance Analytics, and Investor Relations.

“We are delighted to have Atul join the P3 team,” said Dr. Sherif Abdou, P3’s Co-founder and Chief Executive Officer. “He is an accomplished CFO with an extensive background across a wide range of industries. We believe that Atul’s experience in creating value both internally, through a focused ‘talent building’ mindset, and externally by driving financial results, will greatly benefit P3. He will provide sound financial insight and disciplined capital management, as we work to achieve our vision of expanding our value-based care model to lead the transformation of healthcare.”

Mr. Kavthekar succeeds Erin Darakjian who has served as interim CFO since November 1, 2022. Ms. Darakjian remains in her position as Senior Vice President and Chief Accounting Officer.

“I would like to thank Erin for stepping into the CFO role on an interim basis and making the transition seamless, while P3 and its Board of Directors completed the search for a new CFO,” added Dr. Abdou.

Mr. Kavthekar commented, “I am so pleased to join P3 Health Partners, a leader in value-based healthcare. The strength and vision of the team is fueled by a mission-driven culture, which puts the patient at the heart of everything they do. I look forward to helping this team expand through focused, disciplined growth, ensuring greater access to more patients in need.”

During his career, Mr. Kavthekar has served as corporate and divisional CFO for numerous private and public companies, including: EyeCare Partners, Diplomat Pharmacy, Walgreen Co., Sears Holdings Corp., and LivingSocial. Additionally, he has extensive capital markets experience and has held various merger and acquisition roles at leading investment banks, including Morgan Stanley, Wasserstein Perella & Co., and Barclays Capital.

Mr. Kavthekar holds an MBA from the University of Chicago Booth School of Business, a Master of Science in Engineering from Wayne State University, and a Bachelor of Science from the University of Michigan.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Corporate News, Management Changes

Related Entities

Morgan Stanley, Barclays, Earnings, Definitive Agreement